Holdings

T. Rowe Price Health Sciences Fund, Inc.

As of Jun 30, 2026, T. Rowe Price Health Sciences Fund, Inc. reported 161 positions worth US$11.2B. Largest: Eli Lilly and Company, Johnson & Johnson and UnitedHealth Group Incorporated. What it bought and sold, with each filing.

Holdings

Part of
T. Rowe Price
Positions
161
Value as reported
US$11.2B
Holdings as of
Jun 30, 2026
Last filed
Aug 27, 2026
CompanySharesValue as reported% of portfolioChangeAs of
Eli Lilly and Company
NYSE:LLY
1.42MUS$1.71B14.3%+222KJun 30, 2026
Johnson & Johnson
NYSE:JNJ
3.12MUS$792M6.6%+2.03MJun 30, 2026
UnitedHealth Group Incorporated
NYSE:UNH
1.72MUS$716M6.0%+479KJun 30, 2026
AbbVie Inc.
NYSE:ABBV
2.42MUS$609M5.1%+998KJun 30, 2026
Merck & Company, Inc.
NYSE:MRK
3.73MUS$479M4.0%+609KJun 30, 2026
Gilead Sciences, Inc.
NASDAQ:GILD
2.67MUS$337M2.8%+633KJun 30, 2026
Thermo Fisher Scientific Inc
NYSE:TMO
601KUS$301M2.5%−300KJun 30, 2026
Vertex Pharmaceuticals Incorporated
NASDAQ:VRTX
548KUS$272M2.3%−43,160Jun 30, 2026
Bristol-Myers Squibb Company
NYSE:BMY
4.37MUS$252M2.1%NewJun 30, 2026
Abbott Laboratories
NYSE:ABT
2.48MUS$225M1.9%NewJun 30, 2026
Intuitive Surgical, Inc.
NASDAQ:ISRG
563KUS$224M1.9%−301KJun 30, 2026
Amgen Inc.
NASDAQ:AMGN
600KUS$217M1.8%+296KJun 30, 2026
Stryker Corporation
NYSE:SYK
676KUS$213M1.8%−471KJun 30, 2026
Elevance Health, Inc.
NYSE:ELV
472KUS$183M1.5%+228KJun 30, 2026
Natera, Inc.
NASDAQ:NTRA
632KUS$172M1.4%+70,400Jun 30, 2026
Danaher Corporation
NYSE:DHR
894KUS$170M1.4%−282KJun 30, 2026
Guardant Health, Inc.
NASDAQ:GH
976KUS$146M1.2%−80,400Jun 30, 2026
Cardinal Health, Inc.
NYSE:CAH
519KUS$123M1.0%+171KJun 30, 2026
Royalty Pharma plc
NASDAQ:RPRX
2.06MUS$116M0.97%+820KJun 30, 2026
CVS Health Corporation
NYSE:CVS
1.08MUS$112M0.94%−228KJun 30, 2026
Tenet Healthcare Corporation
NYSE:THC
598KUS$112M0.94%+18,200Jun 30, 2026
Kymera Therapeutics, Inc.
NASDAQ:KYMR
925KUS$106M0.89%−77,400Jun 30, 2026
Protagonist Therapeutics, Inc.
NASDAQ:PTGX
829KUS$102M0.85%−314KJun 30, 2026
Moderna, Inc.
NASDAQ:MRNA
1.41MUS$98.9M0.83%+885KJun 30, 2026
BrightSpring Health Services, Inc.
NASDAQ:BTSG
1.41MUS$98.3M0.82%−1.1MJun 30, 2026
Revolution Medicines, Inc.
NASDAQ:RVMD
495KUS$92.8M0.78%−1.02MJun 30, 2026
Roivant Sciences Ltd.
NASDAQ:ROIV
2.37MUS$84M0.70%−2.08MJun 30, 2026
Alnylam Pharmaceuticals, Inc.
NASDAQ:ALNY
266KUS$80.2M0.67%−266KJun 30, 2026
Viatris Inc.
NASDAQ:VTRS
4.95MUS$78.6M0.66%+4.02MJun 30, 2026
Charles River Laboratories International, Inc.
NYSE:CRL
326KUS$74M0.62%+247KJun 30, 2026
argenx SE
EURONEXT:ARGX
76,622US$71.1M0.60%−359KJun 30, 2026
Edwards Lifesciences Corporation
NYSE:EW
780KUS$70.6M0.59%+218KJun 30, 2026
Centene Corporation
NYSE:CNC
1.06MUS$67.9M0.57%+529KJun 30, 2026
Spyre Therapeutics, Inc.
NASDAQ:SYRE
712KUS$63.2M0.53%−142KJun 30, 2026
Definium Therapeutics, Inc.
NASDAQ:DFTX
1.29MUS$60.6M0.51%NewJun 30, 2026
Insmed Incorporated
NASDAQ:INSM
548KUS$58.5M0.49%−154KJun 30, 2026
Twist Bioscience Corporation
NASDAQ:TWST
555KUS$57.1M0.48%NewJun 30, 2026
Chugai Pharmaceutical Co., Ltd.
TSE:4519
1.17MUS$54.1M0.45%+30,600Jun 30, 2026
AstraZeneca PLC
LSE:AZN
279KUS$52.9M0.44%−1.47MJun 30, 2026
United Therapeutics Corporation
NASDAQ:UTHR
96,653US$52.4M0.44%−150KJun 30, 2026
Krystal Biotech, Inc.
NASDAQ:KRYS
139KUS$51.6M0.43%−135KJun 30, 2026
Boston Scientific Corporation
NYSE:BSX
1.2MUS$51.1M0.43%−407KJun 30, 2026
Medtronic plc.
NYSE:MDT
630KUS$49.3M0.41%NewJun 30, 2026
Erasca, Inc.
NASDAQ:ERAS
2.58MUS$47.3M0.40%+1.34MJun 30, 2026
BillionToOne, Inc.
NASDAQ:BLLN
378KUS$45.3M0.38%+113KJun 30, 2026
Praxis Precision Medicines, Inc.
NASDAQ:PRAX
133KUS$44.6M0.37%−55,981Jun 30, 2026
Medpace Holdings, Inc.
NASDAQ:MEDP
84,145US$44.6M0.37%+61,213Jun 30, 2026
Monte Rosa Therapeutics, Inc.
NASDAQ:GLUE
1.82MUS$44.1M0.37%−45,900Jun 30, 2026
Tango Therapeutics, Inc.
NASDAQ:TNGX
1.4MUS$43.8M0.37%+763KJun 30, 2026
Oruka Therapeutics, Inc.
NASDAQ:ORKA
451KUS$42.9M0.36%−24,900Jun 30, 2026
Ascendis Pharma A/S
NASDAQ:ASND
160KUS$42.6M0.36%−516KJun 30, 2026
BeOne Medicines Ltd. Class A
SSE:688235
153KUS$42.3M0.35%−336KJun 30, 2026
Humana Inc.
NYSE:HUM
106KUS$42.2M0.35%NewJun 30, 2026
Dianthus Therapeutics, Inc.
NASDAQ:DNTH
429KUS$41.8M0.35%−54,000Jun 30, 2026
Scholar Rock Holding Corporation
NASDAQ:SRRK
738KUS$40.6M0.34%−632KJun 30, 2026
Kodiak Sciences Inc
NASDAQ:KOD
1.01MUS$39.5M0.33%+92,200Jun 30, 2026
Axsome Therapeutics, Inc.
NASDAQ:AXSM
151KUS$37M0.31%−12,700Jun 30, 2026
Summit Therapeutics Inc.
NASDAQ:SMMT
2.53MUS$36.9M0.31%−3.42MJun 30, 2026
Novo Nordisk A/S Class B
OMXCOP:NOVO_B
762KUS$36.1M0.30%+325KJun 30, 2026
Regeneron Pharmaceuticals, Inc.
NASDAQ:REGN
55,661US$34.7M0.29%−318KJun 30, 2026
Relay Therapeutics, Inc.
NASDAQ:RLAY
1.84MUS$34.4M0.29%+541KJun 30, 2026
Ionis Pharmaceuticals, Inc.
NASDAQ:IONS
434KUS$34.4M0.29%−449KJun 30, 2026
Cytokinetics, Incorporated
NASDAQ:CYTK
395KUS$33.7M0.28%−268KJun 30, 2026
Vera Therapeutics, Inc.
NASDAQ:VERA
784KUS$33.7M0.28%−452KJun 30, 2026
Enliven Therapeutics, Inc.
NASDAQ:ELVN
647KUS$32.9M0.28%+594KJun 30, 2026
Agilent Technologies, Inc.
NYSE:A
245KUS$32.5M0.27%NewJun 30, 2026
MBX Biosciences, Inc.
NASDAQ:MBX
586KUS$32.4M0.27%−135KJun 30, 2026
CG Oncology, Inc.
NASDAQ:CGON
438KUS$31.1M0.26%−671KJun 30, 2026
NewAmsterdam Pharma Company N.V.
NASDAQ:NAMS
913KUS$30.9M0.26%NewJun 30, 2026
Waters Corporation
NYSE:WAT
81,880US$30.7M0.26%NewJun 30, 2026
Crinetics Pharmaceuticals, Inc.
NASDAQ:CRNX
813KUS$30.4M0.25%−281KJun 30, 2026
Madrigal Pharmaceuticals, Inc.
NASDAQ:MDGL
56,364US$30.3M0.25%−18,359Jun 30, 2026
Liquidia Corporation
NASDAQ:LQDA
365KUS$29.1M0.24%+104KJun 30, 2026
Mirum Pharmaceuticals, Inc.
NASDAQ:MIRM
248KUS$29M0.24%+22,600Jun 30, 2026
Beam Therapeutics Inc.
NASDAQ:BEAM
842KUS$28.9M0.24%−252KJun 30, 2026
Nurix Therapeutics, Inc.
NASDAQ:NRIX
1.19MUS$28.8M0.24%−28,513Jun 30, 2026
West Pharmaceutical Services, Inc.
NYSE:WST
77,225US$27.7M0.23%−20,400Jun 30, 2026
IDEAYA Biosciences, Inc.
NASDAQ:IDYA
727KUS$27.1M0.23%+468KJun 30, 2026
BridgeBio Pharma, Inc.
NASDAQ:BBIO
363KUS$27.1M0.23%−501KJun 30, 2026
Teva Pharmaceutical Industries Limited
TASE:TEVA
795KUS$26.9M0.23%NewJun 30, 2026
Rhythm Pharmaceuticals, Inc.
NASDAQ:RYTM
242KUS$26.8M0.22%No changeJun 30, 2026
Viridian Therapeutics, Inc.
NASDAQ:VRDN
1.45MUS$26.6M0.22%+1.1MJun 30, 2026
Alkermes plc
NASDAQ:ALKS
504KUS$26.4M0.22%NewJun 30, 2026
Alignment Healthcare, Inc.
NASDAQ:ALHC
1.07MUS$25.4M0.21%−410KJun 30, 2026
Vaxcyte, Inc.
NASDAQ:PCVX
426KUS$24.8M0.21%+111KJun 30, 2026
Rapport Therapeutics, Inc.
NASDAQ:RAPP
572KUS$23.8M0.20%−29,200Jun 30, 2026
Immunome, Inc.
NASDAQ:IMNM
1.09MUS$23.2M0.19%−573KJun 30, 2026
Palvella Therapeutics, Inc.
NASDAQ:PVLA
144KUS$22M0.18%−8,900Jun 30, 2026
Climb Bio, Inc.
NASDAQ:CLYM
1.64MUS$21.3M0.18%+168KJun 30, 2026
ICON plc
NASDAQ:ICLR
120KUS$20.9M0.17%NewJun 30, 2026
Kailera Therapeutics, Inc.
NASDAQ:KLRA
904KUS$19.9M0.17%NewJun 30, 2026
Celldex Therapeutics, Inc.
NASDAQ:CLDX
495KUS$18.4M0.15%+72,376Jun 30, 2026
Bicara Therapeutics Inc.
NASDAQ:BCAX
591KUS$17.5M0.15%−51,500Jun 30, 2026
Cencora, Inc.
NYSE:COR
61,157US$17.3M0.14%−119KJun 30, 2026
Sonova Holding AG
SIX:SOON
72,348US$17.2M0.14%−33,185Jun 30, 2026
Alumis Inc.
NASDAQ:ALMS
595KUS$16.7M0.14%−594KJun 30, 2026
Apogee Therapeutics, Inc.
NASDAQ:APGE
126KUS$16.7M0.14%−429KJun 30, 2026
ORIC Pharmaceuticals, Inc.
NASDAQ:ORIC
1.53MUS$16.6M0.14%−207KJun 30, 2026
Veeva Systems Inc.
NYSE:VEEV
91,000US$16.1M0.14%NewJun 30, 2026
MoonLake Immunotherapeutics
NASDAQ:MLTX
792KUS$15.4M0.13%−94,957Jun 30, 2026

This page holds 100 of 161 positions.